Publikasi

Is PET Plastic Recyclable?

PET plastic is one of the most common types of plastic used due to its many bene...

What is EPR?: Extended Producer Responsibility for Pack...

Establishing a new way that businesses must account for their packaging use, EPR...

The 7 Types of Plastic

Plastic is an integral material in the pharmaceutical industry, providing safe, ...

Green Pharma: How the industry can reduce its carbon fo...

Dr Supriya Shidhaye outlines how the pharma industry can shrink emissions while...

Merck announces winners of the Merck Young Scientist Aw...

Fourth edition recognises researchers across chemical and biological sciences c...

Cipla launches Ciplostem cell therapy for Knee Osteoart...

DCGI approval marks Cipla’s entry into orthobiologic medicine The post Cipla la...

Corona Remedies announces IPO opening on 8 December 2025

Price band set at ₹1,008–₹1,062 per equity share The post Corona Remedies anno...

India pharma and healthcare funding reaches $38.6 milli...

Early-stage deals account for majority of investment activity The post India ph...

Urgent reforms to ensure safe medicines: Need of the hour

Dr Suresh Saravdekar, former Assistant Director, Ministry of Medical Education ...

Granules India reports completion of FDA inspection wit...

Granules India outlines the inspection outcome and operational role of its U.S....

How Refillable Cosmetic Packaging Is Reshaping Brand St...

Refillable packaging within the cosmetic industry was once a niche idea, but it ...

Tackling Plastic in the Ocean: Origin’s Ocean Polymers

The large scale of waste pollution in the ocean is a leading concern for many ac...

What is Bioresin and How is it Used in Packaging

As the amount of plastic packaging pollution continues to increase, it’s more im...

IASO Bio gains Hong Kong approval for Fucaso application

The therapy is intended for patients who have undergone at least three previous ...

MHRA approves Roche Products’ inavolisib for breast cancer

The approval enables the use of inavolisib in patients whose cancer has recurred...

Eisai seeks PMDA approval for subcutaneous Leqembi in J...

The formulation will serve as a new administration route. Eisai’s application is...